New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts

被引:6
作者
Kui, Peter [1 ]
Orosz, Szabolcs [2 ]
Takacs, Hedvig [3 ,4 ]
Sarusi, Annamaria [1 ]
Csik, Norbert [5 ]
Rarosi, Ferenc [6 ,7 ]
Cseko, Csongor [2 ]
Varro, Andras [1 ,8 ]
Papp, Julius Gy. [1 ,8 ]
Forster, Tamas [3 ,4 ]
Farkas, Attila S. [3 ,4 ]
Farkas, Andras [3 ,4 ]
机构
[1] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary
[2] Gedeon Richter Plc, Budapest, Hungary
[3] Univ Szeged, Dept Med 2, Szeged, Hungary
[4] Univ Szeged, Ctr Cardiol, Szeged, Hungary
[5] Kecskemet Coll, Dept Elect Engn & Cybernet, Kecskemet, Hungary
[6] Univ Szeged, Dept Med Phys & Informat, Szeged, Hungary
[7] Univ Szeged, Bolyai Inst, Szeged, Hungary
[8] Hungarian Acad Sci, MTA SZTE Res Grp Cardiovasc Pharmacol, Szeged, Hungary
基金
匈牙利科学研究基金会;
关键词
ECG; Guinea pig hearts; Langendorff perfusion; Methods; Proarrhythmia; Rate corrected QT interval; Repolarization reserve; Safety screening; Synergism; Torsades de pointes; TORSADES-DE-POINTES; RECTIFIER POTASSIUM CURRENT; REPOLARIZATION RESERVE; DRUG DEVELOPMENT; RABBIT HEARTS; VENTRICULAR REPOLARIZATION; ANESTHETIZED RABBITS; LAMBETH CONVENTIONS; FEMALE GENDER; RISK-FACTOR;
D O I
10.1016/j.vascn.2016.04.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Preclinical in vivo QT measurement as a proarrhythmia essay is expensive and not reliable enough. The aim of the present study was to develop a sensitive, cost-effective, Langendorff perfused guinea pig heart model for proarrhythmia safety screening. Methods: Low concentrations of dofetilide and cisapride (inhibitors of the rapid delayed rectifier potassium current, I-Kr) were tested alone and co-perfused with HMR-1556 (inhibitor of the slow delayed rectifier potassium current, I-Ks) in Langendorff perfused guinea pig hearts. The electrocardiographic rate corrected QT (QTc) interval, the T-peak-T-end interval and the beat-to-beat variability and instability (BVI) of the QT interval were determined in sinus rhythm. Results: Dofetilide and HMR-1556 alone or co-perfused, prolonged the QTc interval by 20 +/- 2%, 10 +/- 1% and 55 +/- 10%, respectively. Similarly, cisapride and HMR-1556 alone or co-perfused, prolonged the QTc interval by 11 +/- 3%, 11 +/- 4% and 38 +/- 6%, respectively. Catecholamine-induced fast heart rate abolished the QTc prolonging effects of the I-Kr inhibitors, but augmented the QTc prolongation during I-Ks inhibition. None of the drug perfusions increased significantly the T-peak-T-end interval and the sinus BVI of the QT interval. Discussion: I-Ks inhibition increased the QTc prolonging effect of I-Kr inhibitors in a super-additive (synergistic) manner, and the QTc interval was superior to other proarrhythmia biomarkers measured in sinus rhythm in isolated guinea pig hearts. The effect of catecholamines on the QTc facilitated differentiation between I-Kr and I-Ks inhibitors. Thus, QTc measurement in Langendorff perfused guinea pig hearts with pharmacologically attenuated repolarization reserve and periodic catecholamine perfusion seems to be suitable for preclinical proarrhythmia screening. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:26 / 34
页数:9
相关论文
共 48 条
  • [1] [Anonymous], 2016, BMC MED, DOI DOI 10.1186/S12916-016-0553-2
  • [2] Arrhythmogenic mechanisms of QT prolonging drugs: Is QT prolongation really the problem?
    Antzelevitch, C
    [J]. JOURNAL OF ELECTROCARDIOLOGY, 2004, 37 : 15 - 24
  • [3] Assessing predictors of drug-induced torsade de pointes
    Belardinelli, L
    Antzelevitch, C
    Vos, MA
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (12) : 619 - 625
  • [4] Do existing measures of Poincare plot geometry reflect nonlinear features of heart rate variability?
    Brennan, M
    Palaniswami, M
    Kamen, P
    [J]. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2001, 48 (11) : 1342 - 1347
  • [5] PROARRHYTHMIC EFFECTS OF THE CLASS-III AGENT ALMOKALANT - IMPORTANCE OF INFUSION RATE, QT DISPERSION, AND EARLY AFTERDEPOLARIZATIONS
    CARLSSON, L
    ABRAHAMSSON, C
    ANDERSSON, B
    DUKER, G
    SCHILLERLINHARDT, G
    [J]. CARDIOVASCULAR RESEARCH, 1993, 27 (12) : 2186 - 2193
  • [6] Cheng Hsien C., 2009, Journal of Pharmacological and Toxicological Methods, V60, P174, DOI 10.1016/j.vascn.2009.05.010
  • [7] Inhibition of L-type Ca2+ current in guinea pig ventricular myocytes by cisapride
    Chiang, CE
    Wang, TM
    Luk, HN
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2004, 11 (03) : 303 - 314
  • [8] The Lambeth Conventions (II): Guidelines for the study of animal and human ventricular and supraventricular arrhythmias
    Curtis, Michael J.
    Hancox, Jules C.
    Farkas, Andras
    Wainwright, Cherry L.
    Stables, Catherine L.
    Saint, David A.
    Clements-Jewery, Hugh
    Lambiase, Pier D.
    Billman, George E.
    Janse, Michiel J.
    Pugsley, Michael K.
    Ng, G. Andre
    Roden, Dan M.
    Camm, A. John
    Walker, Michael J. A.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2013, 139 (02) : 213 - 248
  • [9] Cisapride-induced transmural dispersion of repolarization and torsade de pointes in the canine left ventricular wedge preparation during epicardial stimulation
    Di Diego, JM
    Belardinelli, L
    Antzelevitch, C
    [J]. CIRCULATION, 2003, 108 (08) : 1027 - 1033
  • [10] Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval
    Drolet, B
    Khalifa, M
    Daleau, P
    Hamelin, BA
    Turgeon, J
    [J]. CIRCULATION, 1998, 97 (02) : 204 - 210